Analog Devices: Silicon-Based DNA Synthesis
Daniel Leibholz, Chief Technology Officer, Analog Devices Matthew Hayes, Chief Technology Officer, Evonetix Roman Trogan, Head of R&D, Bioelectronic Platforms, Analog Garage Synthetic biology will have a massive impact across many industries and will be fundamental to enabling a sustainable future, while taking a leading role in the global $4 trillion bioeconomy gold rush. This highly disruptive scientific discipline is likely to achieve significant improvements in DNA synthesis required to enable and facilitate opportunities in biotechnology products not previously attenable.
In Spotlight Sessions
Accenture - Mapping Out New Territory: No More Dragons
Accenture's Fjord Trends 2021 is the essential guide for organizations as they pivot their operations to satisfy unmet human needs, so that we can live and operate in systems that are equal and fit for the challenges of the 21st century.
Accenture: Fast-Tracking the Digital Health Revolution
This session includes a panel of C-suite visionaries and practitioners from Accenture, Zoetis and CommonSpirit Health who will explore what’s in store for the future of digital healthcare.
Deloitte: AI and quantum cyber disruption
We will provide a pragmatic view of these potential impacts and steps you can take today to prepare for tomorrow.
Analog Devices: Ready to Talk to an AI that Interprets Your Asset?
With real industry examples, the visionaries behind ADI Otosense reveal how sensing interpretation AI leverages the best physical-world measurements to derive actionable insights from any machine.
"Redefine the Limits" together with Canon
Hear first-hand from the creators behind Canon's interactive CES experience and how the brand is aiming to redefine the limits in 2021 and far beyond.
Bridgestone - Webfleet Solutions: Opportunity Through Crisis
Learn how telematics is evolving to optimize our mobility ecosystem and how businesses can make use of smart telematics data to help navigate the COVID-19 crisis and beyond.